Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

PING Conference 2022. The Golden Age for Life Science Innovation. WVWPlus logo.

This year’s PING Conference 2022 has a high calibre of inspirational and informative speakers taking part in an entertaining in person format at The Old Palace at Hatfield House, once again sponsored by the Hertfordshire Local Enterprise Partnership.

Hear about how the UK is leading the way in what has been described as the ‘Golden Age for Life Sciences Innovation’ and the opportunities arising from this from leading experts. Be ready to enjoy some themed entertainment with a twist, which will bring the golden age to life.


Speakers include:

  • Matthew Whitty, Director of Innovation, Research & Life Sciences at NHS England & Improvement, and Chief Executive of the Accelerated Access Collaborative – Matthew will talk about The Accelerated Access Collaborative and practical opportunities for industry around innovation, including how the AAC is collaborating with industry, government, regulators, patients and the NHS to remove barriers and accelerate the introduction of ground-breaking new treatments and diagnostics to transform care.


  • Dr Samantha Roberts, Chief Executive of NICE – Samantha will talk about NICE’s latest strategy – maintaining NICE’s global leading role as a robust provider of assessments, whilst responding to changes since COVID-19 and future challenges – including adapting to real world data and being more agile than ever before. This will also cover NICE’s focus on the rapid evaluation of new and emerging products, including diagnostics, medtech, digital health, genomics, advanced therapy medicinal products and “hybrid” technologies. Samantha is new in post at NICE this year and was previously Director of Innovation, Research and Life Sciences at NHS England.


  • George Freeman MP, Minister for Science, Research and Innovation – The Minister will cover enhancing the landscape for early adoption of innovations in the UK, and changing opportunities for financial backing of innovation. Also, why the UK has a unique environment and harnessing the UK’s potential for innovation. Previously the Minister for Life Sciences, and before being elected to Parliament George had a 15 year career across the life sciences sector. Please note: George Freeman will be delivering his speech on screen and will not be at the event in person.


  • Andrew Roddam, Chief Executive Officer at Our Future Health – The holy grail to achieving better health outcomes and justifying paying for treatments is early detection of disease. The UK has led the world with genomics, and now the UK is leading again with an exciting, fast-moving project on health data. Our Future Health is rapidly scaling up to gathering and analysing data about five million people. Hear from Andrew on where the project is at, pharma’s backing of the project to date, and where the opportunities are for utilising this data.


  • Tim Rea, Head of Early Stage Investments at BGF – Fast-growing innovative life sciences companies need cash to fund their growth.  What do investors look for at the various stages of the investment cycle?  What should companies do to make themselves attractive for funding?  What is it about life sciences investment propositions that are attractive to investors?  How does an investor like BGF make a difference?  Hear from the Investor Director at one of the UK’s leading private equity and venture capital investors.

Book your place